Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hypercoagulable states and pregnancy.

¹University of Glasgow, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G3I 2ER, Scotland, UK. I.A.Greer@clinmed.gla.ac.uk

Current Hematology Reports

|August 7, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessment-based management of placenta-mediated pregnancy complications: Pragmatism until a precision medicine approach evolves.

British journal of haematology·2023

Same author

United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale.

Seminars in perinatology·2019

Same author

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Blood advances·2018

Same author

'To test or not to test', the arguments for and against thrombophilia testing in obstetrics.

Obstetric medicine·2017

Same author

LMWH in IVF - Biomarkers and benefits.

Thrombosis research·2017

Same author

Low-molecular-weight heparin for pregnancy complications.

Lancet (London, England)·2016

Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006

Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006

Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006

Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006

Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006

Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006

See all related articles

Pulmonary thromboembolism, a leading cause of maternal death, is linked to deep venous thrombosis. Both conditions may stem from hypercoagulable states, with thrombophilias playing a role in pregnancy complications.

Area of Science:

Obstetrics and Gynecology
Hematology
Vascular Medicine

Background:

Pulmonary thromboembolism (PTE) represents a significant cause of mortality in pregnant individuals in developed nations.
Deep venous thrombosis (DVT) is a primary condition that often underlies PTE.
Both PTE and DVT are frequently associated with an underlying hypercoagulable state, or thrombophilia.

Purpose of the Study:

To explore the role of congenital and acquired thrombophilias in the pathophysiology of venous thromboembolism during pregnancy.
To investigate the association between thrombophilias and other adverse pregnancy outcomes such as miscarriage, intrauterine growth restriction (IUGR), and preeclampsia.
To identify potential new avenues for therapeutic intervention in pregnancy-related thrombotic disorders.

Main Methods:

Related Experiment Videos

Review of existing literature on thrombophilia and pregnancy complications.
Analysis of epidemiological data on maternal mortality related to thromboembolic events.
Correlation studies examining the incidence of thrombophilias in women with recurrent miscarriage, IUGR, and preeclampsia.

Main Results:

Growing evidence supports the implication of thrombophilias in the development of venous thromboembolism (VTE) during pregnancy.
Thrombophilias are increasingly recognized as contributing factors to adverse pregnancy outcomes beyond VTE, including miscarriage, IUGR, and preeclampsia.
Identification of specific thrombophilic states associated with increased risk for these complications.

Conclusions:

Congenital and acquired thrombophilias are critical factors in the pathogenesis of VTE and other adverse pregnancy outcomes.
Understanding these hypercoagulable states opens new possibilities for targeted interventions to improve maternal and fetal health.
Further research is warranted to develop and validate preventative and therapeutic strategies for thrombophilia-related pregnancy complications.